*AMGEN'S REPATHA MET PRIMARY, SECONDARY ENDPOINTS IN TRIAL
Alerts: HALISTER, HALISTER1
Source: BN (Bloomberg News)
Tickers
AMGN US (Amgen Inc)
To de-activate the "HALISTER" alert, click here
To modify this alert, click here
To de-activate the "HALISTER1" alert, click here
To modify this alert, click here
UUID: 7947283
Alerts: HALISTER, HALISTER1
Source: BN (Bloomberg News)
Tickers
AMGN US (Amgen Inc)
To de-activate the "HALISTER" alert, click here
To modify this alert, click here
To de-activate the "HALISTER1" alert, click here
To modify this alert, click here
UUID: 7947283